High surface tumor IgM levels associate with reduced response duration and with BTK bypass during ibrutinib therapy in CLL patients

• Authors: CHIODIN G.; DUTTON D.; MARTINO E.; ONDRIŠOVÁ Laura; PITSILLIDOU Ch.; HENDERSON I.; TRACY I.; DRENNAN S.; D´AVOLA A.; MRÁZ Marek; JOHNSON P.; DUNCOMBE A.; PACKHAM G.; STEELE A.; SCARFO L.; GHIA P.; ROSE-ZERILLI M.; STREFFORD J.; STEVENSON F.; FORCONI F.
• Year of publication: 2019
• Type: Conference abstract
• MU Faculty or unit: Central European Institute of Technology